The biopharmaceutical company Adienne Pharma & Biotech, which will produce the Russian Sputnik V vaccine in Italy, is based in Lugano, Switzerland, but a production plant also in Caponago, in the province of Monza and Brianza. Founded in 2004, over the years it has specialized in the production of niche drugs - we read on its website - often overlooked by large productions, to treat so-called rare or orphan diseases. In particular in the research and marketing of oncohematology, autoimmune diseases, organ and bone marrow transplantation. For his productions he has also received several awards. The company, which signed the first agreement in Europe with the Russian government fund Rdif for the production of Sputnik V in Italy, is chaired by an Italian, Antonio Francesco Di Naro, a long career in the pharmaceutical sector, who is also co- founder of the company.
Vaccini, from July will produce Sputnik at its headquarters in Brianza
2021-03-09T15:37:52.117Z
Pictures of the ADIENNEPharma & Biotech (ANSA) plant The biopharmaceutical company Adienne Pharma & Biotech, which will produce the Russian Sputnik V vaccine in Italy, is based in Lugano, Switzerland, but a production plant also in Caponago, in the province of Monza and Brianza. Founded in 2004, over the years it has specialized in the production of niche drugs - we read on its website - often overlooked by large productions, to treat so-called rare